Valeant Pharma (VRX) option implied volatility elevated into Q1 and outlook

Valeant Pharma (NYSE: VRX) May weekly call option implied volatility is at 117, May is at 80, June is at 55; compared to its 52-week range of 41 to 87 into the expected release of Q1 results before the open on May 8.

You May Also Be Interested In

• Hunterbrook bullish on Modine Manufacturing (MOD)
• Royal Caribbean (RCL) call put ratio 1 call to 1.8 puts amid price movement
• Marriott Vacations Worldwide (VAC) call put ratio 12 calls with a focus on October 105 and 110 calls